← All organizations

VaxGen

For profit

Also known as: VaxGen (v1) | VaxGen (v2)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2004

Acquired by diaDexus on Jan 1, 2010

Timeline

1990s

Jun 1, 1995
VaxGen— Founded

2010s

Jan 1, 2010
diaDexus— Acquired By

Drugs by trial phase (8 distinct, 7 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

aluminum hydroxide

Indications

Studied for

Recent trials (8)

NCT00103584Study directorPhase 1/Phase 2Oct 1, 2004
NCT00103584Lead sponsorPhase 1/Phase 2Oct 1, 2004
NCT00100724Lead sponsorPhase 2Apr 1, 2004
NCT00223080CollaboratorPhase 3Oct 1, 2003
NCT00103467Lead sponsorPhase 1Jun 1, 2003
NCT00002441Lead sponsorPhase 3Nov 2, 1999
NCT00002402Lead sponsorPhase 1Nov 2, 1999
NCT00006327Lead sponsorPhase 3Mar 1, 1999

Details

Founded: South San Francisco, CA, US Jun 1, 1995
Last known activity: Oct 1, 2004